Navigation Links
$4 million AHRQ grant supports research to improve hospital care
Date:10/16/2007

The Agency for Healthcare Research and Quality (AHRQ) has awarded $4 million over the next four years to a University of Chicago-based research team to establish a Center for Education and Research on Therapeutics (CERT) that will focus on the emerging field of hospital medicine and economics.

The grant will help to create "a powerful research and education infrastructure to produce and disseminate knowledge about the use and cost-effectiveness of hospital-based therapy, including drugs, biological products, and devices, said the center's principal investigator, David Meltzer, MD, PhD, associate professor of medicine, economics and public policy at the University of Chicago.

Hospital care has changed radically in the past decade. The use of clinical information systems and systematic approaches to organizing care has increased dramatically. At the same time, hospitalists -- physicians who specialize in the care of hospitalized patients -- have come to play a very large role in the management of such patients. These trends make "the production and dissemination of knowledge about the effective and cost-effective use of hospital therapeutics especially timely and important," Meltzer said.

He will lead a team of 28 experts from diverse backgrounds who will search for ways to improve the effectiveness and reduce the cost of hospital care. Although based at the University of Chicago, the CERT includes researchers from the National Opinion Research Center, the University of Illinois-Chicago School of Pharmacy, the Society for Hospital Medicine, and Consorta, Inc, a national network of more than 500 hospitals.

Research at the Chicago CERT will focus on a series of specific projects, said Meltzer, such as how an individual's genes affect his or her response to warfarin, a difficult-to-manage anti-clotting drug. They will develop new performance measures for treatment of chronic obstructive pulmonary disease, a leading cause of hos
'/>"/>

Contact: Maja Fiket
fi.maja@googlemail.com
773-702-3641
University of Chicago Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Hundred million dollar gift for malaria institute
3. George Bush pledges 200 million dollars for AIDS relief
4. Hope for 11 million children facing death from illnesses
5. The forgotten epidemic killing millions
6. WHO and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005
7. Over Six Million HIV Infected People In South Africa- Finds A Survey
8. Tanzanian Government Sanctions $20 Million For AIDS Arug
9. Grant of $7 million for Orissa Medical College from Japan
10. Merck to pay $ 253.5 million to Vioxx victim family
11. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...al meeting of shareholders to be held on January 8...stCall/ - Med-Emerg International Inc. ("MedEmerg"... of health services, announced today that it has o... Court of Justice concerning its previously announ...nt to which AIM Health Group Inc. ("AIM") will acq...
(Date:11/21/2008)...TON(Nov. 21, 2008)The University of Texas Health S..., Training Excellence in Aging Studies (TEXAS), to...h a prestigious $2 million award from the Donald W...g funds., "This will allow us to teach geriatric ...or medical student to practicing physicians. With ...
(Date:11/21/2008)...AND, Colo., Nov. 21 Hesk...t will present at the New York Society of,Securit...ma Conference on,December 2, 2008 at 1177 Avenue ...resentation is scheduled to begin at 9:35 a.m. Eas...vailable via live webcast and for two weeks,follo...
(Date:11/21/2008)...GTON, Va., Nov. 21 The ...d the following statement today from,GPhA Preside...rade Commission,(FTC) roundtable on "Emerging Hea... "The mere fact that the FTC is conducting this r...d ensuring that consumers have access to safe and,...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...on Minister for Health Anbumani Ramadoss announced...n blood would be set up in the country and one of ...organized by the Tamil Nadu State AIDS Control Soc...ould specialize in Transfusion Medicine. Other ro...
...a study to be published in the August 27 Advance O...feedback loop governing ovarian development have b...icine. Feedback loops are abound in biology and a...ey enable an organ such as the liver to detect if ...
...ef Minister Manik Sarkar inaugurated the Tripura M...vately run medical college-cum-hospital in India's... promoted by Global Educational Net (GENET) in col...is the first public private partnership (PPP) mode...
...mal Health officials have reported finding H5N1 vi...of Ben Tre in Vietnam.// An animal health offic..., "we have received laboratory confirmation that t...ducks on the farm were immediately culled followin...
Other Medicine News:Health News:Feedback Loop Governing Ovarian Development Unraveled 2Health News:Feedback Loop Governing Ovarian Development Unraveled 3Health News:Feedback Loop Governing Ovarian Development Unraveled 4
(Date:11/19/2008)...rstCall/ -- Amgen,(Nasdaq: AMGN ) and Millenniu...akeda Pharmaceutical Company Limited (TSE: 4052), ...NET1 trial evaluating motesanib (AMG 706) in,comb...rst-line treatment of,advanced non-small cell lun...ollowing a planned safety data review of 600 patie...
(Date:11/19/2008)...iotech scientists increasingly are applying genomi...nderstand the effects of novel drug candidates on ...eering & Biotechnology News ( GEN ). They are...und,s mechanism of action and eventually developin...the November 15 issue of GEN . ( http://www.genen...
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX:,NDL), a specialty neuro...any,and Sosei Group Corporation ("Sosei"; TSE Mo...armaceutical company, today announce that NeuroSol... efficacy data for NSL-043/SD118.,This investigat...pain and has,successfully completed Phase I clini...
(Date:11/18/2008)...e/ -- Forty-two leading U. S. scientists and speci...nsider cutting-edge innovations that may defend Am...tbreaks of dangerous zoonotic diseases, the FAZD C...vations: , , , , A "Doc in a Bo...ghly contagious and dangerous zoonotic diseases in...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 1The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 2The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 3The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 4Nestle Nutrition and Phosphagenics to Commence Phospha E 28R 29 Phase 2 Clinical Trial 447 1Nestle Nutrition and Phosphagenics to Commence Phospha E 28R 29 Phase 2 Clinical Trial 447 2Nestle Nutrition and Phosphagenics to Commence Phospha E 28R 29 Phase 2 Clinical Trial 447 3Nestle Nutrition and Phosphagenics to Commence Phospha E 28R 29 Phase 2 Clinical Trial 447 4Malaria product portfolio would benefit from greater cohesion amongst stakeholders 2866 1Malaria product portfolio would benefit from greater cohesion amongst stakeholders 2866 2Malaria product portfolio would benefit from greater cohesion amongst stakeholders 2866 3Majority of Americans want local action on global warming says poll 673 1Majority of Americans want local action on global warming says poll 673 2
...une 4, 2007-A new study published today in the,jou...hat,Cipralex® (escitalopram) was superior to C...f patients with major,depressive disorder (MDD) an...nt. The study directly compared Cipralex® (an,... duloxetine (a,serotonin and noradrenaline reuptak...
...mary endpoints, Wake After Sleep Onset and Total,S...Latency to,Persistent Sleep, were met at both dose...pm UK time, 10am EST) today , HAMBURG, Germany | O...t Stock Exchange: EVT) announced today positive to...ial of EVT 201 in,patients with chronic primary in...
Other Medicine Technology:Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 2Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
Ammonia reagent is used for the quantitative and enzymatic determination of ammonia in human plasma.
The Proteomeworks system is an integrated set of tools and technologies that enables protein function discovery. Innovative new tools for sample preparation, 2-D electrophoresis, staining, imaging an
Medicine Products: